Adarza BioSystems
Latest round
- Series C
Last raised
- Jan 2017
Total raised
- $29M
Investors
- 4
About Adarza BioSystems
Adarza BioSystems, Inc.Founded in 2008 and headquartered in St. Louis, US, Adarza BioSystems, Inc. focuses on biosensing technology.Adarza BioSystems specializes in advanced biosensing technology, with its core product offering centered around the ZIVA™ platform. This innovative technology utilizes laser-based methodologies to provide high-definition insights into the immune response, particularly in relation to SARS-CoV-2 and other health conditions. The platform is designed to address critical end-use cases in the field of immunology and infectious disease diagnostics by enabling researchers and healthcare professionals to obtain precise quantifications of immune markers. Adarza’s customer base primarily includes research laboratories, diagnostic companies, and healthcare institutions that require sophisticated tools for conducting detailed immune response analyses.Adarza BioSystems generates revenue through a structured business model that includes partnerships and direct sales of its proprietary technologies. The company engages with clients primarily through B2B transactions, offering their flagship ZIVA™ platform and associated custom assays for a range of applications. These engagements often involve strategic collaborations with healthcare providers and research organizations that seek to enhance their diagnostic capabilities. Clients typically acquire products through direct purchases, with options for subscription-based services that provide ongoing access to new assays and updates to the platform.In November 2019, Adarza BioSystems, Inc. Specific efforts include the introduction of new assays related to immunology and infectious diseases, with targeted launches expected in the coming years. Additionally, Adarza aims to expand its operations into new geographic regions, focusing on markets in Asia and Europe to enhance its global footprint.
Who invested in Adarza BioSystems
4 investors across 3 rounds
See all investors in Adarza BioSystems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Adarza BioSystems
Who invested in Adarza BioSystems?
Adarza BioSystems has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Adarza BioSystems raised?
Adarza BioSystems has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Adarza BioSystems last raise money?
Adarza BioSystems's most recent round on record is a Series C, in Jan 2017.
What does Adarza BioSystems do?
Adarza BioSystems is a biotechnology company.
Where is Adarza BioSystems headquartered?
Adarza BioSystems is headquartered in St. Louis, US.
Which VCs invest in companies like Adarza BioSystems?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Adarza BioSystems's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Adarza BioSystems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.